Literature DB >> 23221371

Protective role of cardiac CFTR activation upon early reperfusion against myocardial infarction.

Hiromi Uramoto1, Toshiaki Okada, Yasunobu Okada.   

Abstract

BACKGROUND: The cardiac isoform of the cystic fibrosis transmembrane conductance regulator (CFTR) was shown to be activated by β-adrenergic or purinergic stimulation and involved in cell volume regulation after osmotic swelling. Also, cardiac CFTR was reported to be essential in the mechanism by which ischemic preconditioning protects against ischemia/reperfusion(I/ R)-induced injury of the heart. Here, we explored the possibility that activation of cardiac CFTR can provide protection against I/R-induced myocardial infarction, even after ischemic attack.
METHODS: The hearts of wild-type mice were subjected to 30- or 40-min left coronary artery occlusion followed by 2-h or 2-day reperfusion in vivo, and myocardial infarction was examined under a variety of conditions. Neonetal rat ventricular myocytes in primary culture were subjected to hypoxia/reoxygenation in vitro, and necrotic cell death was examined.
RESULTS: The infarct size was much greater in CFTR knockout mice than in wild-type mice. Intravenous infusion of a number of putative CFTR activators upon reperfusion prominently reduced the size of myocardial infarction in wild-type but not CFTR-deficient mice. This protective effect was abolished by co-administration of a CFTR inhibitor. CFTR activators ameliorated, in a manner sensitive to a CFTR inhibitor, release of myocardial-specific creatine kinase isoenzyme to the serum in mice subjected to I/R in vivo. Necrotic death of cultured neonatal rat ventricular myocytes subjected to hypoxia/reoxygenation in vitro was ameliorated by CFTR activators or CFTR gene overexpression but aggravated by a CFTR inhibitor or CFTR gene silencing.
CONCLUSION: It is concluded that activation of endogenous myocardial CFTR upon early reperfusion is involved in protection against necrotic myocardial injury induced by I/R in vivo and in vitro. Cardiac CFTR may serve as a target accessible even after ischemic attack for pharmacotherapeutic intervention in I/R-induced myocardial infarction.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23221371     DOI: 10.1159/000341479

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

1.  Cl- channels in apoptosis.

Authors:  Podchanart Wanitchakool; Jiraporn Ousingsawat; Lalida Sirianant; Nanna MacAulay; Rainer Schreiber; Karl Kunzelmann
Journal:  Eur Biophys J       Date:  2016-06-07       Impact factor: 1.733

Review 2.  Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Authors:  Adriano R Tonelli
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

Review 3.  Ion channels in regulated cell death.

Authors:  Karl Kunzelmann
Journal:  Cell Mol Life Sci       Date:  2016-04-18       Impact factor: 9.261

4.  Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia.

Authors:  Alexey A Lagunin; Sergey M Ivanov; Tatyana A Gloriozova; Pavel V Pogodin; Dmitry A Filimonov; Sandeep Kumar; Rajesh K Goel
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

Review 5.  Mechanobiology in cardiac physiology and diseases.

Authors:  Ken Takahashi; Yoshihide Kakimoto; Kensaku Toda; Keiji Naruse
Journal:  J Cell Mol Med       Date:  2013-02       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.